Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7M Sell
381,074
-173,498
-31% -$3.71M 0.04% 546
2026
Q1
$11.2M Buy
554,572
+105,435
+23% +$2.34M 0.07% 334
2025
Q4
$8.61M Sell
449,137
-18,602
-4% -$391K 0.15% 163
2025
Q3
$11.3M Buy
467,739
+133,883
+40% +$3.13M 0.11% 188
2025
Q2
$6.5M Buy
333,856
+17,564
+6% +$260K 0.07% 363
2025
Q1
$4.07M Buy
316,292
+6,401
+2% +$103K 0.06% 445
2024
Q4
$5.34M Buy
309,891
+15,109
+5% +$302K 0.08% 356
2024
Q3
$6.65M Buy
+294,782
New +$6.74M 0.1% 275

Other funds holding ADNT

Empowered Funds's ADNT Position: Q2 2026 in Review

Empowered Funds reduced its Adient (ADNT) stake by 31% in Q2 2026, selling an estimated $3.71M and leaving 381,074 shares worth $7M. The position accounts for 0.04% of the portfolio, ranked #546.

Empowered Funds first reported a position in ADNT in Q3 2024 and has held it in 8 quarters since. The position peaked at $11.3M in Q3 2025. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Empowered Funds held 381,074 shares of Adient worth $7M as of Q2 2026.
  • Empowered Funds sold 173,498 Adient shares in Q2 2026, an estimated $3.71M.
  • Adient made up 0.04% of Empowered Funds's portfolio in Q2 2026, its #546 holding.
  • Empowered Funds first reported a position in Adient in Q3 2024 and has held it in 8 quarters since.
  • Empowered Funds's Adient position peaked at $11.3M in Q3 2025.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.